Tag: Vancomycin alternatives

Recent studies indicate that the effectiveness of vancomycin is increasingly challenged by emerging resistance, particularly in methicillin-resistant Staphylococcus aureus (MRSA) strains with higher minimum inhibitory concentrations (MICs). This phenomenon, coupled with vancomycin's well-documented side effects, underscores the urgent need to understand what drug can replace vancomycin for effective and safe treatment.

The emergence of methicillin-resistant *Staphylococcus aureus* (MRSA) has posed a significant public health concern since the 1960s [1.2.4]. This has led to the pivotal question for clinicians: in the face of resistance and treatment challenges, **what antibiotic is better than vancomycin?**